The roles of insulin-like growth factor I (IGF-I) and hyperglycemia in the development of gut hyperplasia, which was found in insulin-deficient animals, were studied. Ornithine decarboxylase (ODC), a rate-limiting enzyme in the de novo synthesis of polyamines, has important regulatory roles in epithelial cell proliferation in the small intestine. In IEC-6 cells, a model epithelial cell line, IGF-I (100 nM) stimulated ODC mRNA expression six fold, ODC enzyme activity 19-fold, and [
3H] thymidine incorporation rates four fold as compared with the control. The IGF-I-induced stimulation of [
3H] thymidine incorporation was inhibited by the simultaneous addition of difluoromethylornithine (DFMO; 5 mM) and this DFMO-induced inhibition was abolished by treatment with 10 μM putrescine. Moreover, the IGF-I-induced ODC enzyme activation was totally prevented by treatment with actinomycin D (4 μM), suggesting the importance of ODC mRNA expression in cell proliferation induced by IGF-I. Furthermore, increased concentrations of glucose in the culture medium had an additive effect on IGF-I-stimulated ODC activation and [
3H] thymidine incorporation in IEC-6 cells. Since the increased glucose concentration in the culture medium had no effect on ODC mRNA expression with or without IGF-I, its effect on ODC activity was induced through post-transcriptional control. These results suggest that IGF-I and hyperglycemia may play important roles in the small intestinal hyperplasia in insulin-deficient diabetic animals.
View full abstract